Skip to main content

Biomedical, Clinical & Life Sciences

Drug Delivery Faculty Starter Grant

No Applicants // Limit: 1 predoc, postdoc, or faculty member per lab

Limiting Language
Only one applicant per lab may apply in the Drug Delivery Program. Labs must select either a predoc, a postdoc, or a faculty member.

Program Overview
The PhRMA Foundation Faculty Starter Grant in Drug Delivery offers financial support to individuals beginning independent careers at the faculty level at an accredited U.S. university in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering. The funding amount is $100,000 for one year.

Funding Type
External Deadline
4/15/2026 (LOI); 8/26/2026 (Full Application - by invitation)

W.M. Keck Foundation: Science & Engineering AND Medical Research Programs - Fall 2026 Deadline

Internal Competition Undergoing Peer Review // Limit: 8 Concept Papers, 2 Phase I Proposals (1 Medical Research, 1 Science and Engineering)

 Program Description

Full sponsor guidelines: https://www.wmkeck.org/research-overview/

The mandate of the W.M. Keck Research Program is to support pioneering discoveries in Science, Engineering, and Medical Research.  The Foundation funds the high-risk and high-impact work of leading researchers to lay the groundwork for new paradigms, technologies, and discoveries that will save lives, provide innovative solutions and add to our understanding of the world.

Keck funded projects are distinctive and novel in their approach, question the prevailing paradigm, or have the potential to break open new territory in their field.  We prioritize grants that pioneer biological and physical science research and engineering, including the development of promising new technologies, instrumentation or methodologies.

Fit Self-Test: A Keck-ready idea can answer “yes” to most of the following questions:

  • Does it discover how something works?
  • Does it challenge an existing assumption?
  • Is failure still scientifically valuable?
  • Would federal agencies likely say, “too early”?

Keck Prioritizes:

  • Work that is paradigm shifting, or challenges a prevailing hypothesis
  • Work that creates a new field, or bridges disparate fields
  • Work that departs from current approaches or challenges existing assumptions or frameworks
  • Fundamental basic science questions focused on how systems work and the underlying mechanisms that govern them
  • Discovery-driven logic
  • Research where failure is informative

Keck Disfavors:

  • Clinical or translational research (i.e., development of therapeutics)
  • Outcome or patient impact framing
  • Biomarkers as endpoints
  • Engineering for its own sake
  • Large mammal studies when they function as clinical or validation trials
  • Already funded or derivative work

Important notes:

  • Keck seeks to fund basic science that advances fundamental understanding
  • Keck funds science, not engineering – unless engineering is essential to answer a scientific question
  • Keck funds medical research, not clinical research
  • Federal rejection is not required, but Keck fills gaps where federal agencies are too risk adverse.
  • Keck does not consider tools, platforms, or methods as the primary idea. Tools, AI, and engineering may be supported only if required to answer a basic scientific question. 
Funding Type
Internal Deadline
External Deadline
11/1/2026 (Phase I)
Solicitation Type

2027 Pew Biomedical Scholars

Internal Competition Undergoing Peer Review // Limit: 1 // Tickets Available: 1

Limiting Language
For the 2027 award, one nomination will be invited from each of the participating institutions listed at the bottom of this page.

Program Overview
The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level.

Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Ideas with the potential to produce an unusually high impact are encouraged. Selection of the successful candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. In evaluating the candidates, the National Advisory Committee gives considerable weight to both the project proposal and the researcher, including evidence that the candidate is a successful independent investigator and has the skill set needed to carry out their high-impact proposal.

Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew scholars program. If you have questions concerning eligibility, please contact Pew Biomedical Programs (scholarsapp@pewtrusts.org) in advance of applying.

Eligibility

  • Hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
  • As of Sept. 3, 2026, run an independent lab and hold a full-time appointment at the rank of assistant professor. (Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible).
  • Current appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible to apply.
  • Must not have been appointed as an assistant professor and run an independent lab at any institution prior to June 10, 2023, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this three-year limit. Candidates who need an exception on the three-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
  • May apply to the program a maximum of two times. All applicants must be nominated by their institution and must complete the 2027 online application.
  • If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
  • May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.
Funding Type
Internal Deadline
External Deadline
5/13/2026 (Nomination); 9/3/2026 (Application)
Solicitation Type

Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)

Institutionally Coordinated // Limit: 1 

Limiting Language
Only one application per institution (identified by NIH IPF number) is allowed.

Purpose
This Notice of Funding Opportunity (NOFO) solicits applications to develop shared-use research facilities or research-supporting facilities that enable collaborative research and benefit broad research communities at large. The NOFO supports two existing construction programs: the Biomedical Research Facilities (BRF) program and the HIV/AIDS Research Facilities (HRF) program.

The BRF program supports the construction or modernization of biomedical research facilities that advance basic, translational, clinical, or behavioral science research in all areas. Intended facilities include shared research spaces, core facilities, biorepositories, or other shared-use resource facilities that serve a broad scientific community with a significant, long-term impact on biomedical research.

The HRF program funds the development of HIV/AIDS research or research-supporting resources that the empowered research activities must align with the NIH Office of AIDS Research (OAR) priorities, as outlined at OAR HIV/AIDS Research Priorities, including research focusing on the long-term health consequences of HIV infection.

NIH encourages applications from institutions across all geographic regions of the country, including Institutions of Emerging Excellence (IEE) in biomedical research, to strengthen the nation’s research capacity.

2026 Native American Agriculture Fund’s (NAAF) Grant Program

Request Ticket // Limit: 2* // Tickets Available: 1

General Funding - Limit: 1 // Tickets Available: 0
N. Pier (Cooperative Extension - Maricopa County)

Youth Funding - Limit: 1 // Tickets Available: 1

*Limiting Language
An organization is allowed to submit one application for General funding, and one application for Youth funding. General applications can include funding requests for multiple categories, so long as the applicant is an eligible entity for the project described and so long as a separate narrative of the project and a separate budget and budget justification are included for each component of the project is included in the application. 

There is one category in the 2026 RFA for General and Youth. You may apply for categories as you are eligible but can only submit one project budget for each category. 

Introduction and Background
Welcome to the Native American Agriculture Fund’s (NAAF) grant application process for 2026. The information below describes projects and ideas for which NAAF seeks applications and provides details about submission requirements and clarification of expectations applying to all applicants seeking funding.

NAAF was created from cy pres funds attributable to the settlement of the Keepseagle v. Vilsack litigation. A history of the litigation leading to the creation of NAAF can be found on the NAAF website at NativeAmericanAgricultureFund.org/about/. The final Court approval of the amended settlement in the case occurred in 2018, and in late July 2018, the Trustees of NAAF executed the NAAF Trust Agreement. A copy of the Trust Agreement that launched NAAF into existence can also be found on the NAAF website at NativeAmericanAgricultureFund.org/trustagreement/. We strongly recommend reading the Trust Agreement before starting an application for funding.  

NAAF seeks applications that align with a variety of programmatic areas. These areas are informed by strategic planning activities, grantmaking outcomes and online survey responses. For the 2026 funding cycle, applications are sought across a wide variety of projects across several topical areas.  

NAAF is directed to fund grant projects for a total of twenty (20) years until the year 2038, and in so doing, hopes to make a significant impact across as many Native communities as possible. This 2026 RFA represents the eigth (8th) funding cycle for NAAF. Ongoing input about the needs of Native farmers and ranchers from eligible entities is extremely valuable. We encourage all applicants and stakeholders to start a dialogue with NAAF via the NAAF survey instrument to achieve the promise provided by the creation of NAAF. 

Funding Type
External Deadline
5/1/2026
Solicitation Type

2026 Mallinckrodt Grants

Limit: 1 // Tickets Available: 0

M. Corty (Neuroscience)

Limiting Language
Institutions may submit one proposal per session. Interested candidates should work through their sponsored projects office.

Grant Guidelines
The mission of the Foundation is to support early stage investigators engaged in basic biomedical research that has the potential to significantly advance the understanding, diagnosis or treatment of disease.

The funds are designed to provide to tenure track faculty members in their first to fourth year, at American Institutions, who hold M.D. and/or Ph.D. degrees, start-up support to move the project forward to the point where R01 or other independent funding can be obtained.  Applicants with current R01 or similar funding should not apply.  

Beginning in 2023, the grant provides $75,000 annually for a period of up to three years.  Grants are not renewable.  Institutions may submit one proposal per session.  Interested candidates should work through their sponsored projects office.

Funding Type
Internal Deadline
External Deadline
7/1/2026
Solicitation Type

Feed the Future Innovation Labs

Limit: 2* // Tickets Available: 0

Z. Guido (Arizona Institute for Resilience)
G. Barron-Gafford (School of Geography Development and Environment)

Limiting Language
Applicants may submit up to two (2) applications as the Management Entity (ME).

Note: Coordination with other eligible applicants and use of a consortia approach is acceptable. In addition to applying as a Management Entity, an organization may partner as a sub awardee under other eligible applications.

Executive Summary
America First investments in agricultural research through the FtF Innovation Labs benefit the world’s poorest regions while also providing major benefits to the United States. The Department of State invites eligible applicants to advance global food security in alignment with U.S. policy through targeted research that meets one or both of the following core objectives:

  1. Advances agricultural science and research to increase productivity, mitigate threats to production systems, and support food systems to reduce hunger and malnutrition through enhanced supply of nutritious and safe foods; and/or
  2. Increases demand for individual and household consumption of nutritious, safe foods as part of healthy diets, and improves market pathways and opportunities for government and private sector actors to promote consumption of nutritious and safe foods.

The Management Entity of each respective FtF Innovation Lab is expected to help implement and communicate impact pathways from research to development outcomes via partnerships with other USG programs, national partners, private companies, community-based organizations, such as faith-based organizations, and other donors and their programs. Programs must ensure U.S. investments directly benefit American safety, strength, and prosperity. Proposals should clearly address how the research activities will support both global food security and U.S. national security and economic interests, reduce the need for repeated humanitarian assistance, expand market access for U.S. companies, and protect the U.S agriculture industry.

Funding Type
External Deadline
4/9/2026

2026 Breast Cancer Alliance - Young Investigator Grants (YIG) and Exceptional Project Grants (XP)

Limit: 1 // Tickets Available: 0

YIG - S. Adamo (Radiology and Imaging Sciences) 

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language
The University of Arizona Cancer Center (UACC) can nominate one proposal for the Breast Cancer Alliance Research Awards - either for the Young Investigator Grant (YIG) OR Exceptional Project Grant (XP) 2026.

Purpose of Award:

Breast Cancer Alliance provides seed money – scientific venture capital – to fund innovative breast cancer research with emphases on programs that have not yet qualified for federal grants. To secure federal funding, a researcher must prove a theory works. Breast Cancer Alliance creates the critical bridge between novel research and the opportunity to generate preliminary results with grants like our Exceptional Projects.

BCA encourages careers in breast cancer research and in clinical medicine. We award two year Young Investigator Grants to doctors and scientists in the early stages of their careers, often overlooked by the funding world until they have longer tenure. 

  • YIG:
    • Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for a Young Investigator Grant.
    • This award helps advance the careers of young researchers who do not yet have their own major grant support, but who design and conduct their own independent research projects.
  • XP:
    • Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant.
    • This award recognizes creative, unique and innovative research related to breast cancer.
Funding Type
Internal Deadline
External Deadline
3/31/2026 (Nomination); 6/30/2026 (Invited Full Application)
Solicitation Type

2026 V Foundation Pediatric Cancer Research Grant

No Applicants // Limit: 2* // Tickets Available: 2 

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language
The University of Arizona Cancer Center (UACC) can nominate can nominate up to two proposals: one Translational OR V Scholar nominee and one All-Star nominee (if eligible) for the V Foundation Pediatric Cancer Research Grant 2026.

Purpose of Award
The UACC is seeking nominations for the Pediatric Cancer Research Grant which is restricted to pediatric cancer research. Research on ANY pediatric cancer type can be funded. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Applicant Eligibility
Nominee must meet all of the following criteria by the nomination due date:

  • Nominated by their Cancer Center Director or similar high ranking research official.
  • Employed at a non-profit research institution (e.g., 501c3, Section 170).
  • Either a US Citizen or a permanent legal resident in the US
  • See additional criteria for each mechanism listed in corresponding RFA within the Supporting Documents section above.

Funding Information per mechanism

  • V Scholar: A four-year grant totaling $800,000 (paid in annual installments of $200,000). No indirect costs allowed.
  • Translational: A four-year grant totaling $800,000 (paid in annual installments of $200,000). This amount includes both direct and indirect costs. Indirect costs are allowed up to 10% of total grant amount.
  • All Star: A five-year grant totaling, $1,000,000 (paid in annual installments of $200,000). This amount includes both direct and indirect costs. Indirect costs are allowed up to 10% of total grant amount.

The V Foundation follows NIH salary cap guidelines. Institutions may supplement a grant recipient’s salary with institutional funds, if desired.


 

Funding Type
Internal Deadline
External Deadline
3/23/2026 (Nomination); 4/23/2026 (Full Application)

Retirement Research Foundation: Responsive Grants

Request Ticket // Limit: One LOI per College

Y. Shirai (Family and Community Medicine // College of Medicine - Tucson) 

Limiting Language
Organizations may submit only one Letter of Inquiry per deadline. Common exceptions include LOIs submitted by separate departments of large universities. Per clarification with RRF, the University of Arizona may submit one LOI per college per deadline. 

Program Description

Full sponsor guidelines are linked here

RRF Foundation for Aging focuses on improving the quality of life for older people. In an effort to strengthen the Foundation’s impact, RRF has established Priority Areas. These Priority Areas are specific topics in aging that will be given higher priority within the Foundation’s grantmaking program.

Types of Grants

  1. Advocacy: Achieve enduring social change around issues that affect older Americans
  2. (Ineligible - for applicants in Illinois only) Direct Service: Improve availability and quality of community-based services and supports in seven states
  3. Research: Seek causes and solutions to significant problems for older persons
  4. Knowledge Sharing and Awareness Raising: Knowledge sharing and awareness-raising projects that convey meaningful information, shape narratives, and drive positive change.
  5. (Ineligible - for applicants in Illinois only) Organizational Capacity Building: Improve management and governance of non-profit organizations


 

Funding Type
Internal Deadline
External Deadline
5/1/2026 (Required LOI); 8/5/2026 (Invited Full Proposal)
Solicitation Type